Zinc in PDB 3ebz: High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Enzymatic activity of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
All present enzymatic activity of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir:
3.4.23.47;
Protein crystallography data
The structure of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir, PDB code: 3ebz
was solved by
A.Y.Kovalevsky,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
10.00 /
1.20
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.408,
30.827,
55.768,
90.00,
91.41,
90.00
|
R / Rfree (%)
|
13.6 /
18.1
|
Other elements in 3ebz:
The structure of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
(pdb code 3ebz). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 9 binding sites of Zinc where determined in the
High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir, PDB code: 3ebz:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
Zinc binding site 1 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 1 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn403
b:19.9
occ:0.50
|
O
|
A:HOH1011
|
1.4
|
17.1
|
0.5
|
N3
|
A:IMD304
|
2.0
|
17.4
|
0.5
|
CL
|
A:CL503
|
2.1
|
18.8
|
0.5
|
OXT
|
A:LEU99
|
2.2
|
34.6
|
1.0
|
O
|
A:HOH1009
|
2.2
|
15.5
|
0.5
|
O
|
A:HOH1010
|
2.4
|
17.3
|
0.5
|
O
|
A:LEU99
|
2.7
|
38.7
|
1.0
|
C2
|
A:IMD304
|
2.8
|
21.2
|
0.5
|
C
|
A:LEU99
|
2.8
|
28.4
|
1.0
|
C4
|
A:IMD304
|
3.2
|
19.4
|
0.5
|
N1
|
A:IMD304
|
4.0
|
23.8
|
0.5
|
O
|
A:HOH1148
|
4.0
|
37.9
|
0.5
|
C5
|
A:IMD304
|
4.2
|
21.1
|
0.5
|
CA
|
A:LEU99
|
4.4
|
25.5
|
1.0
|
|
Zinc binding site 2 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 2 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn405
b:21.8
occ:0.50
|
O
|
A:HOH1030
|
1.6
|
30.9
|
0.5
|
OD2
|
A:ASP79
|
2.0
|
26.4
|
1.0
|
O
|
A:HOH1029
|
2.2
|
28.5
|
0.5
|
CG
|
A:ASP79
|
2.8
|
22.9
|
1.0
|
OD1
|
A:ASP79
|
2.9
|
29.8
|
1.0
|
CB
|
A:ASP79
|
4.2
|
19.5
|
1.0
|
O
|
A:HOH1186
|
4.2
|
44.8
|
1.0
|
|
Zinc binding site 3 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 3 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn406
b:26.8
occ:0.50
|
N3
|
A:IMD306
|
2.1
|
24.2
|
0.5
|
O
|
A:HOH1007
|
2.1
|
25.8
|
0.5
|
OE1
|
A:GLU65
|
2.2
|
45.0
|
1.0
|
CD
|
A:GLU65
|
2.7
|
46.2
|
1.0
|
OE2
|
A:GLU65
|
2.7
|
51.4
|
1.0
|
C2
|
A:IMD306
|
2.7
|
25.6
|
0.5
|
C4
|
A:IMD306
|
3.3
|
22.7
|
0.5
|
O
|
A:HOH1197
|
3.4
|
30.5
|
0.2
|
N1
|
A:IMD306
|
4.0
|
23.5
|
0.5
|
CG
|
A:GLU65
|
4.1
|
37.6
|
1.0
|
C5
|
A:IMD306
|
4.3
|
23.1
|
0.5
|
CB
|
A:GLU65
|
4.6
|
28.6
|
1.0
|
CD1
|
A:TYR14
|
5.0
|
37.0
|
1.0
|
CG
|
A:TYR14
|
5.0
|
35.3
|
1.0
|
|
Zinc binding site 4 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 4 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn401
b:12.6
occ:1.00
|
OE2
|
B:GLU121
|
1.9
|
14.3
|
1.0
|
N3
|
B:IMD301
|
2.0
|
11.7
|
1.0
|
N3
|
B:IMD302
|
2.0
|
18.6
|
1.0
|
CD
|
B:GLU121
|
2.7
|
11.2
|
1.0
|
C2
|
B:IMD302
|
2.9
|
23.1
|
1.0
|
OE1
|
B:GLU121
|
2.9
|
17.2
|
1.0
|
C2
|
B:IMD301
|
3.0
|
15.1
|
1.0
|
C4
|
B:IMD301
|
3.0
|
12.1
|
1.0
|
C4
|
B:IMD302
|
3.1
|
25.8
|
1.0
|
O
|
B:HOH1152
|
3.9
|
34.3
|
1.0
|
N1
|
B:IMD302
|
4.1
|
31.6
|
1.0
|
CG
|
B:GLU121
|
4.1
|
9.9
|
1.0
|
N1
|
B:IMD301
|
4.1
|
13.0
|
1.0
|
C5
|
B:IMD301
|
4.2
|
13.7
|
1.0
|
O
|
B:HOH1146
|
4.2
|
38.1
|
1.0
|
C5
|
B:IMD302
|
4.2
|
29.6
|
1.0
|
CG1
|
B:VAL110
|
4.6
|
17.9
|
1.0
|
O
|
B:HOH1159
|
4.6
|
46.1
|
1.0
|
|
Zinc binding site 5 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 5 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn402
b:13.9
occ:0.60
|
ZN
|
B:ZN409
|
1.7
|
25.1
|
0.4
|
OD2
|
B:ASP130
|
1.9
|
22.4
|
1.0
|
N3
|
B:IMD303
|
1.9
|
11.0
|
0.6
|
O
|
B:HOH1002
|
2.1
|
13.6
|
0.6
|
CL
|
B:CL502
|
2.4
|
12.1
|
0.6
|
C4
|
B:IMD303
|
2.9
|
13.1
|
0.6
|
CG
|
B:ASP130
|
3.0
|
14.8
|
1.0
|
C2
|
B:IMD303
|
3.0
|
10.3
|
0.6
|
OD1
|
B:ASP130
|
3.4
|
22.5
|
1.0
|
C27
|
B:017201
|
3.9
|
11.7
|
1.0
|
CL
|
B:CL508
|
4.0
|
26.7
|
0.4
|
O
|
A:HOH1184
|
4.0
|
38.2
|
0.5
|
C5
|
B:IMD303
|
4.1
|
12.9
|
0.6
|
N1
|
B:IMD303
|
4.1
|
11.8
|
0.6
|
CB
|
B:ASP130
|
4.3
|
11.4
|
1.0
|
OD2
|
B:ASP129
|
4.5
|
20.4
|
1.0
|
O28
|
B:017201
|
4.5
|
13.1
|
1.0
|
O26
|
B:017201
|
4.6
|
10.7
|
1.0
|
CB
|
B:ASP129
|
4.6
|
13.5
|
1.0
|
CG2
|
B:VAL147
|
4.6
|
13.0
|
1.0
|
C31
|
B:017201
|
4.8
|
11.9
|
1.0
|
CG1
|
B:VAL147
|
4.9
|
14.6
|
1.0
|
CE
|
B:MET176
|
4.9
|
35.2
|
0.6
|
|
Zinc binding site 6 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 6 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn404
b:18.9
occ:0.50
|
O
|
B:HOH1006
|
1.8
|
14.8
|
0.5
|
N3
|
B:IMD305
|
2.1
|
15.3
|
0.5
|
O
|
B:HOH1004
|
2.2
|
15.8
|
0.5
|
CL
|
B:CL506
|
2.2
|
27.4
|
0.5
|
CL
|
B:CL505
|
2.3
|
17.0
|
0.5
|
C2
|
B:IMD305
|
3.0
|
15.3
|
0.5
|
C4
|
B:IMD305
|
3.2
|
13.8
|
0.5
|
CB
|
B:TRP106
|
4.0
|
21.3
|
1.0
|
N1
|
B:IMD305
|
4.2
|
15.5
|
0.5
|
O
|
B:HOH1112
|
4.2
|
39.8
|
1.0
|
C5
|
B:IMD305
|
4.3
|
14.6
|
0.5
|
CG
|
B:LYS107
|
4.3
|
21.7
|
1.0
|
CD
|
B:LYS107
|
4.5
|
20.8
|
1.0
|
CD1
|
B:TRP106
|
4.6
|
25.0
|
1.0
|
O
|
B:HOH1103
|
4.6
|
39.1
|
1.0
|
N
|
B:LYS107
|
4.6
|
14.9
|
1.0
|
O
|
B:HOH1086
|
4.6
|
30.4
|
1.0
|
CE
|
B:LYS107
|
4.6
|
29.7
|
1.0
|
CG
|
B:TRP106
|
4.7
|
21.1
|
1.0
|
CA
|
B:TRP106
|
4.9
|
16.1
|
1.0
|
CB
|
B:LYS107
|
4.9
|
19.8
|
1.0
|
N
|
B:TRP106
|
4.9
|
16.2
|
1.0
|
CB
|
B:SER104
|
4.9
|
26.1
|
1.0
|
C
|
B:TRP106
|
5.0
|
16.1
|
1.0
|
|
Zinc binding site 7 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 7 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn407
b:28.7
occ:0.50
|
O
|
B:HOH1005
|
1.8
|
26.5
|
0.5
|
O
|
B:HOH1003
|
1.8
|
21.8
|
0.5
|
OE1
|
B:GLU165
|
1.9
|
58.3
|
1.0
|
CL
|
B:CL504
|
2.2
|
23.5
|
0.5
|
CD
|
B:GLU165
|
2.8
|
34.8
|
1.0
|
O
|
B:HOH1008
|
3.0
|
43.2
|
0.5
|
OE2
|
B:GLU165
|
3.1
|
45.3
|
1.0
|
O
|
B:HOH1028
|
3.8
|
12.8
|
1.0
|
CG
|
B:GLU165
|
4.1
|
19.7
|
1.0
|
CA
|
B:GLY117
|
4.9
|
12.9
|
1.0
|
|
Zinc binding site 8 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 8 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 8 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn408
b:25.0
occ:0.50
|
OE1
|
B:GLU158
|
2.0
|
29.6
|
1.0
|
O
|
B:HOH1001
|
2.0
|
21.0
|
0.5
|
CL
|
B:CL507
|
2.2
|
25.4
|
0.5
|
O
|
B:HOH1170
|
2.4
|
20.1
|
0.5
|
CD
|
B:GLU158
|
2.9
|
20.0
|
1.0
|
OE2
|
B:GLU158
|
3.3
|
26.6
|
1.0
|
O
|
B:HOH1123
|
3.8
|
22.3
|
0.5
|
CG
|
B:GLU158
|
4.3
|
14.3
|
1.0
|
CE
|
B:MET176
|
4.3
|
30.6
|
0.4
|
CE
|
B:LYS145
|
4.5
|
19.1
|
1.0
|
NZ
|
B:LYS145
|
4.5
|
20.7
|
1.0
|
O
|
B:HOH1133
|
4.6
|
26.4
|
0.5
|
C5
|
B:IMD303
|
4.6
|
12.9
|
0.6
|
CG2
|
B:THR174
|
4.7
|
14.5
|
1.0
|
CE
|
B:MET176
|
4.8
|
35.2
|
0.6
|
O
|
B:HOH1098
|
5.0
|
27.9
|
1.0
|
|
Zinc binding site 9 out
of 9 in 3ebz
Go back to
Zinc Binding Sites List in 3ebz
Zinc binding site 9 out
of 9 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 9 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn409
b:25.1
occ:0.40
|
ZN
|
B:ZN402
|
1.7
|
13.9
|
0.6
|
O
|
B:HOH1002
|
1.8
|
13.6
|
0.6
|
OD2
|
B:ASP130
|
2.2
|
22.4
|
1.0
|
CL
|
B:CL508
|
2.3
|
26.7
|
0.4
|
N3
|
B:IMD303
|
2.4
|
11.0
|
0.6
|
OD1
|
B:ASP130
|
2.5
|
22.5
|
1.0
|
C4
|
B:IMD303
|
2.5
|
13.1
|
0.6
|
CG
|
B:ASP130
|
2.7
|
14.8
|
1.0
|
C2
|
B:IMD303
|
3.7
|
10.3
|
0.6
|
C5
|
B:IMD303
|
3.9
|
12.9
|
0.6
|
CB
|
B:ASP129
|
3.9
|
13.5
|
1.0
|
CL
|
B:CL502
|
4.0
|
12.1
|
0.6
|
OD2
|
B:ASP129
|
4.1
|
20.4
|
1.0
|
CB
|
B:ASP130
|
4.2
|
11.4
|
1.0
|
N1
|
B:IMD303
|
4.4
|
11.8
|
0.6
|
CG
|
B:ASP129
|
4.5
|
17.9
|
1.0
|
O
|
A:HOH1184
|
4.7
|
38.2
|
0.5
|
N
|
B:ASP130
|
4.7
|
9.5
|
1.0
|
C27
|
B:017201
|
4.8
|
11.7
|
1.0
|
O
|
B:HOH1170
|
4.9
|
20.1
|
0.5
|
C
|
B:ASP129
|
4.9
|
10.5
|
1.0
|
CE
|
B:MET176
|
4.9
|
35.2
|
0.6
|
CA
|
B:ASP130
|
4.9
|
10.1
|
1.0
|
O
|
B:HOH1098
|
4.9
|
27.9
|
1.0
|
|
Reference:
A.Y.Kovalevsky,
J.M.Louis,
A.Aniana,
A.K.Ghosh,
I.T.Weber.
Structural Evidence For Effectiveness of Darunavir and Two Related Antiviral Inhibitors Against Hiv-2 Protease J.Mol.Biol. V. 384 178 2008.
ISSN: ISSN 0022-2836
PubMed: 18834890
DOI: 10.1016/J.JMB.2008.09.031
Page generated: Thu Oct 24 12:43:23 2024
|